Joinn Laboratories(China)Co.,Ltd.
603127
주식 순위
#3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
주가
$6.82
시가총액
$4.30B
변동 (1일)
-6.30%
변동 (1년)
48.79%
국가
CN
거래 Joinn Laboratories(China)Co.,Ltd. (603127)
카테고리
Healthcare
Joinn Laboratories(China)Co.,Ltd. (603127)의 주식 분할 이력
Joinn Laboratories(China)Co.,Ltd. 주식 (심볼: 603127)은 총 6회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Jul 25, 2023에 발생했습니다.
May 31, 2018 이전에 매수한 603127 주식 1주는 현재 7.529536주의 603127 주식에 해당합니다.
가장 최근의 분할은 Jul 25, 2023에 발생했습니다.
May 31, 2018 이전에 매수한 603127 주식 1주는 현재 7.529536주의 603127 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 2023-07-25 | 7:5 | x1.4 | x7.529536 |
| 2022-08-08 | 7:5 | x1.4 | x5.37824 |
| 2021-08-05 | 7:5 | x1.4 | x3.8416 |
| 2020-06-08 | 7:5 | x1.4 | x2.744 |
| 2019-04-10 | 7:5 | x1.4 | x1.96 |
| 2018-05-31 | 7:5 | x1.4 | x1.4 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 3 | x2 |
CN
|
|
| 1 | x1 |
US
|
